Pictet & Cie (Europe) Sa Eli Lilly & CO Transaction History

Pictet & Cie (Europe) Sa

$4.19 Billion
Q3 2024

A detailed history of Pictet & Cie (Europe) Sa transactions in Eli Lilly & CO stock. As of the latest transaction made, Pictet & Cie (Europe) Sa holds 62,190 shares of LLY stock, worth $47.7 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares

62,190

Previous 61,485 1.15%

Holding current value

$47.7 Million

Previous $55.7 Million 1.03%

% of portfolio

1.31%

Previous 1.36%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$772.14 - $960.02 $544,358 - $676,814	705 Added 1.15%	62,190 $55.1 Million
Q2 2024 Jul 25, 2024	SELL	$724.87 - $909.04 $8.86 Million - $11.1 Million	-12,219 Reduced 16.58%	61,485 $55.7 Million
Q1 2024 May 07, 2024	BUY	$592.2 - $792.28 $9.29 Million - $12.4 Million	15,687 Added 27.04%	73,704 $57.3 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $2.14 Million - $2.52 Million	4,070 Added 7.54%	58,017 $33.8 Million
Q3 2023 Nov 02, 2023	SELL	$434.7 - $599.3 $59,119 - $81,504	-136 Reduced 0.25%	53,947 $29 Million
Q2 2023 Aug 08, 2023	BUY	$350.74 - $468.98 $307,248 - $410,826	876 Added 1.65%	54,083 $25.4 Million
Q1 2023 May 01, 2023	BUY	$310.63 - $364.82 $15.6 Million - $18.3 Million	50,269 Added 1710.99%	53,207 $18.3 Million
Q4 2022 Feb 08, 2023	SELL	$321.55 - $374.67 $287,787 - $335,329	-895 Reduced 23.35%	2,938 $0
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $4,150 - $4,730	-14 Reduced 0.36%	3,833 $1.24 Billion
Q2 2022 Aug 05, 2022	SELL	$278.73 - $327.27 $224,098 - $263,125	-804 Reduced 17.29%	3,847 $1.25 Million
Q1 2022 May 04, 2022	BUY	$234.69 - $291.66 $51,162 - $63,581	218 Added 4.92%	4,651 $1.33 Million
Q4 2021 Feb 02, 2022	BUY	$224.85 - $279.04 $446,552 - $554,173	1,986 Added 81.16%	4,433 $1.22 Million
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $25,927 - $31,907	-117 Reduced 4.56%	2,447 $565,000
Q2 2021 Aug 11, 2021	BUY	$180.55 - $233.54 $101,830 - $131,716	564 Added 28.2%	2,564 $588,000
Q4 2020 Feb 11, 2021	BUY	$130.46 - $172.63 $260,920 - $345,260	2,000 New	2,000 $338,000
Q4 2018 Jan 31, 2019	SELL	$105.9 - $118.64 $219,742 - $246,178	-2,075 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$85.86 - $107.31 $7.51 Million - $9.39 Million	-87,520 Reduced 97.68%	2,075 $223,000
Q2 2018 Aug 10, 2018	BUY	$75.7 - $86.88 $510,218 - $585,571	6,740 Added 8.13%	89,595 $7.65 Million
Q1 2018 May 09, 2018	BUY	$74.21 - $87.6 $822,098 - $970,432	11,078 Added 15.43%	82,855 $6.41 Million
Q4 2017 Feb 09, 2018	BUY	$81.94 - $87.89 $147,492 - $158,202	1,800 Added 2.57%	71,777 $6.06 Million
Q3 2017 Nov 07, 2017	BUY	$77.07 - $85.54 $1.3 Million - $1.44 Million	16,827 Added 31.66%	69,977 $5.99 Million
Q2 2017 Aug 09, 2017	BUY	N/A	53,150	53,150 $4.37 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.

Account

Pictet & Cie (Europe) Sa Eli Lilly & CO Transaction History